| Identification | Back Directory | [Name]
3H-Imidazo[4,5-b]pyridine, 2-butyl-5-methyl-6-(1-oxido-2-pyridinyl)-3-[[2'-(2H-tetrazol-5-yl)[1,1'-biphenyl]-4-yl]methyl]- | [CAS]
174800-22-7 | [Synonyms]
3H-Imidazo[4,5-b]pyridine, 2-butyl-5-methyl-6-(1-oxido-2-pyridinyl)-3-[[2'-(2H-tetrazol-5-yl)[1,1'-biphenyl]-4-yl]methyl]- | [Molecular Formula]
C30H28N8O | [MOL File]
174800-22-7.mol | [Molecular Weight]
516.6 |
| Hazard Information | Back Directory | [Uses]
KR-31080 is an derivative of imidazo [4,5-b] pyridine. KR-31080 inhibits angiotensin II receptor. KR-31080 inhibits the NO production in LPS-stimulated BV-2 cells at a concentration of 2 μm with inhibition of 8.3%[1]. | [References]
[1] Jiyeon Ock, et al. A novel anti-neuroinflammatory pyridylimidazole compound KR-31360. Biochem Pharmacol. 2010 Feb 15;79(4):596-609. DOI:10.1016/j.bcp.2009.09.026 |
|
| Company Name: |
TargetMol
|
| Telephone: |
400-821-0310 15002144251 |
| Website: |
www.targetmol.cn/ |
|